GlassScriptPhysician profile
Amit Hooda
NPI 1598395469
$39,962.34
in general payments reported to CMS, 2019-2025
36 companies · $4,517 in 2025
The $4,517 reported for 2025 was more than what 82% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $1,833 · 2021: $19K · 2022: $8,215 · 2023: $4,409 · 2024: $1,663 · 2025: $4,517.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,986 · Grant: $2,000 · Travel and Lodging: $1,604.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,985.67 |
| Grant | $2,000.00 |
| Travel and Lodging | $1,603.57 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $13,973.02 | 2021-2025 | Corevalve Evolut R, Hawkone, In.Pact Admiral |
| Abbott Laboratories | $4,734.38 | 2021-2024 | Optis, Mitraclip, Jeti |
| Boston Scientific Corporation | $4,251.37 | 2020-2025 | General - Catheter, General - Therapies |
| Shockwave Medical, INC | $3,588.76 | 2021-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Edwards Lifesciences Corporation | $1,502.17 | 2021-2025 | Sapien 3 Ultra Resilia |
| Osprey Medical INC | $1,250.00 | 2022 | |
| Amgen INC. | $1,176.36 | 2021-2025 | Repatha |
| Terumo Medical Corporation | $1,007.86 | 2020-2024 | Metacross Otw, Angio-Seal, Glidewire |
| Cordis US Corp. | $932.55 | 2021-2025 | Selution Slr Ptca |
| Abiomed | $894.36 | 2020-2025 | Impella |
| Astrazeneca Pharmaceuticals LP | $861.66 | 2020-2024 | Farxiga, Andexxa |
| Chiesi USA, INC. | $824.02 | 2020-2023 | Kengreal, Cleviprex |
| Cardiva Medical, INC. | $659.65 | 2020-2025 | Cardiva Vascade 5f Vcs, Savvywire, Cardiva Vascade Mvp Vvcs 6-12f |
| Biotronik INC. | $578.35 | 2021-2024 | |
| E.R. Squibb & Sons, L.L.C. | $535.81 | 2020-2023 | Camzyos |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $458.86 | 2020-2024 | |
| Novartis Pharmaceuticals Corporation | $424.27 | 2022-2025 | |
| Cardiovascular Systems INC. | $422.83 | 2021 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $398.40 | 2020-2023 | Lifevest |
| Janssen Pharmaceuticals, INC | $314.62 | 2020-2023 | Xarelto |
| Philips North America LLC | $231.21 | 2020-2024 | (Ck4) Mcot |
| W. L. Gore & Associates, INC. | $171.68 | 2021-2022 | |
| Esperion Therapeutics, INC. | $167.99 | 2025 | Nexletol |
| Penumbra, INC. | $91.26 | 2020-2021 | |
| Scpharmaceuticals INC. | $85.90 | 2024-2025 | |
| Heartflow, INC. | $84.31 | 2020-2025 | |
| Cook Medical LLC | $51.86 | 2023 | Zilver Ptx |
| Asahi Intecc USA, INC. | $44.59 | 2022-2023 | Asahi Ptca Guide Wire |
| Novo Nordisk INC | $42.42 | 2024 | Wegovy |
| Acutus Medical, INC. | $40.44 | 2020 | |
| Getinge USA Sales, LLC | $38.11 | 2020 | |
| Biobeat USA INC. | $34.96 | 2024 | Bb-613 Bpm Kit |
| Kiniksa Pharmaceuticals International, Plc | $34.33 | 2024 | Arcalyst |
| Cardinal Health 200 LLC | $28.06 | 2020 | |
| Teleflex LLC | $25.92 | 2023 | Turnpike |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amit Hooda listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.